ALKEM LABORATORIES
Quarterly Results Analysis [Dec2023]
ALKEM LABORATORIES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹3,324 Cr | ₹3,440 Cr | ₹2,968 Cr | ₹2,903 Cr | ₹3,041 Cr | ₹3,079 Cr | ₹2,576 Cr | ₹2,484 Cr |
Expenses | ₹2,616 Cr | ₹2,693 Cr | ₹2,579 Cr | ₹2,549 Cr | ₹2,442 Cr | ₹2,625 Cr | ₹2,373 Cr | ₹2,147 Cr |
Operating Income | ₹708 Cr | ₹747 Cr | ₹389 Cr | ₹353 Cr | ₹599 Cr | ₹454 Cr | ₹203 Cr | ₹337 Cr |
Other Income | ₹94 Cr | ₹63 Cr | ₹66 Cr | ₹69 Cr | ₹45 Cr | ₹51 Cr | ₹51 Cr | ₹21 Cr |
Interest | ₹25 Cr | ₹30 Cr | ₹30 Cr | ₹29 Cr | ₹27 Cr | ₹25 Cr | ₹27 Cr | ₹17 Cr |
Depreciation | ₹70 Cr | ₹74 Cr | ₹72 Cr | ₹78 Cr | ₹78 Cr | ₹77 Cr | ₹76 Cr | ₹83 Cr |
Profit Before Tax | ₹655 Cr | ₹648 Cr | ₹353 Cr | ₹212 Cr | ₹539 Cr | ₹402 Cr | ₹152 Cr | ₹243 Cr |
Profit After Tax | ₹604 Cr | ₹615 Cr | ₹288 Cr | ₹68 Cr | ₹460 Cr | ₹348 Cr | ₹131 Cr | ₹108 Cr |
EPS | ₹49.77 | ₹51.90 | ₹23.98 | ₹5.94 | ₹38.04 | ₹27.67 | ₹10.68 | ₹9.00 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALKEM LABORATORIES | 2.8% | -7.7% | 54.1% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
ALKEM LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -3.38 % |
Y-o-Y | 9.31 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹3,324 Cr | -3.38 | |
Sep2023 | ₹3,440 Cr | 15.92 | |
Jun2023 | ₹2,968 Cr | 2.24 | |
Mar2023 | ₹2,903 Cr | -4.55 | |
Dec2022 | ₹3,041 Cr | -1.25 | |
Sep2022 | ₹3,079 Cr | 19.52 | |
Jun2022 | ₹2,576 Cr | 3.72 | |
Mar2022 | ₹2,484 Cr | - |
ALKEM LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -5.24 % |
Y-o-Y | 18.12 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹708 Cr | -5.24 | |
Sep2023 | ₹747 Cr | 91.87 | |
Jun2023 | ₹389 Cr | 10.17 | |
Mar2023 | ₹353 Cr | -41.03 | |
Dec2022 | ₹599 Cr | 31.98 | |
Sep2022 | ₹454 Cr | 123.34 | |
Jun2022 | ₹203 Cr | -39.73 | |
Mar2022 | ₹337 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -1.93 % |
Y-o-Y | 8.07 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 21.29% | -1.93 | |
Sep2023 | 21.71% | 65.60 | |
Jun2023 | 13.11% | 7.72 | |
Mar2023 | 12.17% | -38.22 | |
Dec2022 | 19.7% | 33.65 | |
Sep2022 | 14.74% | 86.82 | |
Jun2022 | 7.89% | -41.90 | |
Mar2022 | 13.58% | - |
ALKEM LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -1.73 % |
Y-o-Y | 31.38 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹604 Cr | -1.73 | |
Sep2023 | ₹615 Cr | 113.64 | |
Jun2023 | ₹288 Cr | 325.25 | |
Mar2023 | ₹68 Cr | -85.29 | |
Dec2022 | ₹460 Cr | 32.28 | |
Sep2022 | ₹348 Cr | 164.53 | |
Jun2022 | ₹131 Cr | 21.48 | |
Mar2022 | ₹108 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 1.73 % |
Y-o-Y | 20.16 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 18.18 % | 1.73 | |
Sep2023 | 17.87 % | 84.23 | |
Jun2023 | 9.7 % | 316.31 | |
Mar2023 | 2.33 % | -84.60 | |
Dec2022 | 15.13 % | 34.01 | |
Sep2022 | 11.29 % | 121.37 | |
Jun2022 | 5.1 % | 16.97 | |
Mar2022 | 4.36 % | - |
ALKEM LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -4.10 % |
Y-o-Y | 30.84 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹49.77 | -4.10 | |
Sep2023 | ₹51.9 | 116.43 | |
Jun2023 | ₹23.98 | 303.70 | |
Mar2023 | ₹5.94 | -84.38 | |
Dec2022 | ₹38.04 | 37.48 | |
Sep2022 | ₹27.67 | 159.08 | |
Jun2022 | ₹10.68 | 18.67 | |
Mar2022 | ₹9 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD